Photoswitchable optoGPCRs for reversible control of Gs signalling and arrestin recruitment
This study presents optoDRD1, a novel photoswitchable optoGPCR engineered from the bistable jumping spider rhodopsin JSR1-S199F and the dopamine D1 receptor, which enables robust, reversible, and bidirectional control of Gs signaling and arrestin recruitment using distinct violet and green light wavelengths for applications in dissecting dopaminergic physiology and GPCR pharmacology.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of a preprint that has not been peer-reviewed. It is not medical advice. Do not make health decisions based on this content. Read full disclaimer
Inside every cell of the human body, there are tiny molecular machines that act as gatekeepers, deciding when to let a signal pass through and when to stop it. These machines are called G protein-coupled receptors, or GPCRs. They sit on the cell's surface and listen for chemical messages from hormones or neurotransmitters. When they hear the right message, they flip a switch inside the cell, triggering a chain reaction that tells the cell to grow, move, or release a substance. Because these receptors control so many vital processes, from heart rate to mood, they are the targets for a huge number of medicines. Scientists have long wanted to control these switches with perfect precision, turning them on and off at will to understand how they work or to treat diseases. For years, researchers have used light to control similar switches in bacteria, but the human versions of these receptors have been much harder to tame with light.
A team of researchers has now built a new tool that allows them to control a specific type of human receptor using light, with the ability to turn the signal on and off repeatedly without the tool wearing out. They created a hybrid molecule that combines the light-sensing ability of a spider's eye protein with the internal signaling parts of a human dopamine receptor. This new tool, which they named optoDRD1, can be activated by violet light to start a cellular signal and then instantly switched off by green light. Unlike previous versions of such tools that would fade away after a single use, this new design stays stable and can be toggled back and forth many times. This breakthrough gives scientists a way to study how dopamine, a chemical linked to movement and reward, controls the body's internal machinery with a level of timing and control that was previously impossible.
The journey to this new tool began with a protein found in the jumping spider Hasarius adansoni. This spider uses a special light-sensitive protein in its eyes to see, and scientists had already discovered that a specific version of this protein, with a single tiny change in its structure, could act like a reversible light switch. In its natural state, this spider protein responds to light by changing shape, but it usually gets stuck in one position. The researchers found that by changing just one building block in the protein, they could make it switch between an active state and an inactive state depending on the color of light hitting it. Violet light would turn it on, and green light would turn it off, allowing the protein to cycle between these two states over and over again. However, this spider protein naturally triggers a different kind of signal inside human cells than what the researchers wanted to study. It was good at triggering signals related to muscle contraction and calcium, but the team wanted to control a signal related to dopamine, which involves a different pathway called the Gs pathway. This pathway is crucial for regulating heart function, learning, and blood sugar levels, but there were very few tools available to control it with light.
To solve this, the scientists decided to build a chimera, a hybrid protein that takes the light-sensing core from the spider and grafts onto it the internal parts of a human dopamine receptor. They knew that the part of the receptor that senses light is on the outside, but the part that talks to the cell's internal machinery is on the inside. By swapping the internal loops and the tail of the spider protein with those from the human dopamine receptor, they hoped to create a molecule that could be turned on by light but would send the correct dopamine-related signal inside the cell. They used computer models to predict how these new hybrid proteins would look and behave, focusing on how well the internal parts would fit together to send a signal. They tested many different combinations, swapping various sections of the human receptor into the spider protein, and measured how much of a chemical signal called cAMP was produced when the cells were exposed to light.
The results showed that one specific combination worked far better than the others. This winning design, which the team called optoDRD1, included four specific parts from the human dopamine receptor: two loops and a tail section. When they tested this molecule in human cells, they found that a brief flash of violet light could trigger a strong signal that lasted for hours, mimicking the effect of dopamine binding to a natural receptor. More importantly, they could stop this signal at any time by shining green light on the cells, which immediately turned the receptor off. The signal would stay off until they flashed violet light again. This bidirectional control is a major advantage over older tools that could only be turned on and then would fade away on their own or required a chemical drug to turn off. The researchers confirmed that this new tool was highly sensitive, responding to light intensities that are safe and achievable in living tissues, and it could be switched on and off repeatedly for at least six hours without losing its ability to work.
The team also checked if this new tool behaved like the natural human dopamine receptor in other ways. They found that it recruited the same internal proteins that natural receptors do, and it triggered the same type of cellular response. To prove its usefulness, they tested it in two different types of cells that are relevant to human health. First, they used it in human pancreatic beta cells, which are responsible for releasing insulin. When they turned on the optoDRD1 with violet light, the cells released more insulin, showing that the tool could control a real physiological process. Next, they tested it in nerve cells, where it successfully controlled the chemical signals that neurons use to communicate. In both cases, the light-controlled switch worked just as well as the natural chemical receptors, but with the added benefit that the scientists could decide exactly when to start and stop the signal.
One of the most surprising findings was that this tool could work even without the special light-sensitive molecule that is usually required to make these proteins functional. The researchers found that the tool could incorporate a common form of retinal, a vitamin A derivative found in many tissues, to become active. This means that in a living animal, the tool might not need to be supplemented with special chemicals to work, as it could potentially use the retinal already present in the body. However, they also noted that this common form of retinal could sometimes keep the receptor slightly active even in the dark, which might require a quick flash of green light to reset before an experiment begins. Despite this small caveat, the ability to use a naturally occurring molecule makes the tool much more practical for future studies in living organisms.
The creation of optoDRD1 represents a significant step forward in the field of optogenetics, which uses light to control biological processes. By combining the stability and reversibility of a spider's light sensor with the specific signaling power of a human dopamine receptor, the researchers have created a versatile tool that can be used to dissect complex biological pathways. This tool allows scientists to turn specific signals on and off with the precision of a light switch, offering a new way to study how dopamine affects the brain, how insulin is released, and how other Gs-coupled receptors function. The ability to control these processes with light, without the need for drugs that might have side effects or linger in the body, opens up new possibilities for understanding disease mechanisms and developing new treatments. The researchers demonstrated that this approach is robust and reliable, providing a solid foundation for future experiments that require precise temporal control over cellular signaling.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.